bullish

Moderna

Quiddity Leaderboard Nasdaq100 Dec26 Rebal: 3 ADDs/DELs; US$42bn One-Way Flow

has highlighted this Insight as a Top Pick
150 Views02 Oct 2026 16:56
Moderna replacing WBD is the last expected intra-review change before December. The annual reconstitution should bring three more Nasdaq-100 changes and ~US$42bn of one-way flow.
What is covered in the Full Insight:
  • Introduction
  • Index Selection Criteria
  • Selection Process - Annual Reconstitution
  • Indicative Timeline
  • Conclusions
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Quiddity Leaderboard Nasdaq100 Dec26 Rebal: 3 ADDs/DELs; US$42bn One-Way Flow
    02 Oct 2026
x